These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28893782)

  • 1. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
    Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    Anan N; Toba S; Ito A; Nakamura R; Tsuji M
    Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
    Breen SKJ; Harper M; López-Causapé C; Rogers KE; Tait JR; Smallman TR; Lang Y; Lee WL; Zhou J; Zhang Y; Bulitta JB; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Int J Antimicrob Agents; 2024 Jun; 63(6):107161. PubMed ID: 38561094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.
    Maiden MM; Zachos MP; Waters CM
    J Antimicrob Chemother; 2019 Apr; 74(4):894-906. PubMed ID: 30624737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K; Ishida A; Chinzei T
    Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    Yamashiro Y; Ogake N; Takahata M; Minami S
    Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
    Weiss K; Lapointe JR
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
    Dundar D; Otkun M
    Yonsei Med J; 2010 Jan; 51(1):111-6. PubMed ID: 20046523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
    Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
    Clark RB; Pakiz CB; Hostetter MK
    Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
    Angehrn P
    Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.
    Bergen PJ; Forrest A; Bulitta JB; Tsuji BT; Sidjabat HE; Paterson DL; Li J; Nation RL
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5134-42. PubMed ID: 21876058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
    Sears SD; Tatem BA; Standiford HC
    Chemotherapy; 1985; 31(2):102-11. PubMed ID: 3921317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
    Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.